Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Comment: Expense of Amphotericin B Product

Annals of Pharmacotherapy

Impact Factor: 2.5 / 5-Year Impact Factor: 2.7

Journal Homepage Submission guidelines

Restricted access

Letter

First published online November, 1996

Comment: Expense of Amphotericin B Product

Volume 30, Issue 11

https://doi.org/10.1177/106002809603001127

Abstract

Get full access to this article

View all access options for this article.

References

1.

Cleary

JD

. Amphotericin B formulated in a lipid emulsion. Ann Pharmacother 1996; 30: 409–12.

2.

Pascual

B

Ayestaran

A

Montoro

JB

Oliveras

J

Estibalez

A

Julia

A

. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia. Ann Pharmacother 1995; 29: 1197–201.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Available access

Degeneration and Dysfunction of Retinal Neurons in Acute Ocular Hypertensive Rats: Involvement of Calpains

Available access

i Drugs and i Devices Discovery Research: Preclinical Assays,Techniques,and Animal Model Studies for Ocular Hypotensives and Neuroprotectants

Available access

Eyes on New Product Development

Available access

The Effects of Commercially Available Preservative-Free FDA-Approved Triamcinolone (Triesence ® ) on Retinal Cells in Culture